Cure Pharmaceutical Holding Corp. (CURR)
NASDAQ · Technology
Cure Pharmaceutical Holding Corp. Income Statement 2023–2024
| Dec 2024 | Dec 2023 | |
|---|---|---|
| Revenues | ||
| Revenue | 46.4M | 53.3M |
| Gross Profit | 14.6M | 17.4M |
| Profitability | ||
| Operating Income | -27.4M | -6.6M |
| EBITDA | — | — |
| Net Income | -39.5M | -15.3M |
| Per Share Data | ||
| EPS (diluted) | — | — |
| Shares Outstanding (dil.) | 38M | 34M |
Cure Pharmaceutical Holding Corp. Income Statement — FAQ
Cure Pharmaceutical Holding Corp. (CURR) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CURR's income statement history?
The chart and table above show Cure Pharmaceutical Holding Corp.'s income statement by year and by quarter, including the growth rate.